Search Results for keywords:"Health and Human Services Department"

The National Institute of Mental Health is holding a closed meeting on February 4, 2025, from 3:00 p.m. to 5:00 p.m. to review and evaluate grant applications under the BRAIN Initiative. The meeting will be conducted virtually and is closed to the public to protect personal privacy and confidential information. Rebecca Steiner Garcia is the Scientific Review Officer overseeing this meeting. The meeting is part of the federal mental health research grant program.

The National Heart, Lung, and Blood Institute is announcing a virtual meeting of the National Heart, Lung, and Blood Advisory Council on April 23, 2025. The meeting is open to the public and will be videocast on the NIH website. Those interested in attending or making an oral presentation should contact Charisee Lamar in advance. Security procedures for visitors and additional information about the meeting can be found on the NIH website.

The Eunice Kennedy Shriver National Institute of Child Health and Human Development has announced a closed meeting of its Initial Review Group's Function, Integration, and Rehabilitation Sciences Study Section. This meeting, scheduled for June 23-24, 2025, will be held virtually from 10:00 a.m. to 6:00 p.m. The agenda will focus on reviewing and evaluating grant applications, which contain confidential information. Due to the sensitive nature of the discussions, the public is not allowed to attend. Interested parties can contact Dr. Helen Huang for more information.

This document announces a closed meeting of the National Center for Advancing Translational Sciences Special Emphasis Panel scheduled for April 29, 2025. The meeting will be virtual and is closed to the public to protect sensitive information, such as trade secrets and personal details. During the meeting, contract proposals related to the development of drug substances will be reviewed. For further details, Dr. Rahat Khan can be contacted at the National Institutes of Health.

The National Cancer Institute has announced that there will be closed meetings where grant applications will be reviewed. These meetings are not open to the public to protect trade secrets, personal privacy, and commercial property. One meeting will happen on April 14, 2025, focusing on reviewing specific cancer research program projects. Another meeting is scheduled for April 16-17, 2025, to evaluate informatics technologies for cancer research. The meetings will take place virtually, and the responsible contacts are Leila B. Toulabi, Ph.D., and Susan Lynn Spence, Ph.D.

The National Institute of Neurological Disorders and Stroke (NINDS) has announced a closed meeting in accordance with federal regulations. The meeting is scheduled for April 18 and April 22, 2025, and will be conducted virtually. It is intended for the review and evaluation of grant applications related to neurological sciences. The closed nature of the meeting is to protect confidential information and personal privacy.

The Food and Drug Administration (FDA) has released a draft guidance titled "Protocol Deviations for Clinical Investigations of Drugs, Biological Products, and Devices." This document aims to help sponsors, clinical investigators, and institutional review boards define, identify, and report protocol deviations effectively during clinical investigations. It offers definitions and a classification system for reporting these deviations, allowing consistent documentation and interpretation. Comments on the draft can be submitted electronically or in writing by February 28, 2025, to help shape the final guidance.

The National Institute of Neurological Disorders and Stroke is changing the dates for their upcoming special meeting. Originally scheduled for February 25-26, 2021, the meeting will now take place on April 14-15, 2021. The meeting will still be held at the Neuroscience Center in Rockville, Maryland, and it remains closed to the public. The timing of the meeting will stay the same as initially planned.

The Centers for Disease Control and Prevention (CDC) announced a closed meeting for the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel. This meeting, scheduled for February 25-26, 2025, and to be held via web conference, will focus on reviewing grant applications related to identifying and evaluating potential risk factors for ALS. The meeting is closed to the public to protect confidential information and personal privacy. For more details, individuals can contact Scientific Review Officer Carlisha Gentles.

The Food and Drug Administration (FDA) has delayed the effective date of the rule defining the term "healthy" on food labels from February 25, 2025, to April 28, 2025, following a presidential memorandum on regulatory freeze. The rule updates how and when the term "healthy" can be used to help consumers identify nutritious foods according to current dietary guidelines. This delay allows for additional review, and although the rule's compliance date isn't until 2028, companies can start following it before then if they choose.